American Journal of Ophthalmology
Volume 149, Issue 1 , Pages 54-61.e2 , January 2010

Clinical Benefits of the Boston Ocular Surface Prosthesis

  • William B. Stason

      Affiliations

    • Schneider Institutes for Health Policy Heller School, Brandeis University, Waltham, Massachusetts
    • Corresponding Author InformationInquiries to William B. Stason, Schneider Institutes for Health Policy, Heller School, MS 035, Brandeis University, Waltham, MA 02454
    • ,
  • Moaven Razavi

      Affiliations

    • Schneider Institutes for Health Policy Heller School, Brandeis University, Waltham, Massachusetts
    • ,
  • Deborah S. Jacobs

      Affiliations

    • Boston Foundation for Sight, Needham, Massachusetts
    • ,
  • Donald S. Shepard

      Affiliations

    • Schneider Institutes for Health Policy Heller School, Brandeis University, Waltham, Massachusetts
    • ,
  • Jose A. Suaya

      Affiliations

    • Schneider Institutes for Health Policy Heller School, Brandeis University, Waltham, Massachusetts
    • ,
  • Lynnette Johns

      Affiliations

    • Boston Foundation for Sight, Needham, Massachusetts
    • ,
  • Perry Rosenthal

      Affiliations

    • Boston Foundation for Sight, Needham, Massachusetts

,Accepted 22 July 2009.

References 

  1. Javitt JC, Zhou Z, Willke RJ. Association between vision loss and higher medical care costs in Medicare beneficiaries. Ophthalmology. 2007;114:238–245
  2. US National Eye Institute. Facts about the cornea and corneal diseases (Keratoconus). Updated November 2008 http:www.nei.nih.gov/health/cornealdisease/index.asp#hAccessed: November 10, 2008
  3. Jacobs DS, Rosenthal P. Boston scleral lens prosthetic device for treatment of ocular surface disease in chronic graft-versus-host disease. Cornea. 2007;26:1195–1999
  4. Romero-Rangel T, Stavrou P, Cotter J, Rosenthal P, Baltatzis S, Foster CS. Gas-permeable scleral contact lens therapy in ocular surface disease. Am J Ophthalmol. 2000;130:25–32
  5. Rosenthal P, Cotter JM, Baum J. Treatment of persistent corneal epithelial defect with extended wear of a fluid-ventilated gas-permeable scleral contact lens. Am J Ophthalmol. 2000;130:33–41
  6. Rosenthal P, Croteau A. Fluid-ventilated, gas-permeable scleral contact lens is an effective option for managing severe ocular surface disease and many corneal disorders that would otherwise require penetrating keratoplasty. Eye Contact Lens. 2004;31:130–134
  7. Takahide K, Parker PM, Wu M, et al. Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2007;13:1016–1021
  8. Shepard DS, Razavi M, Stason WB, et al. Economics of the Boston ocular surface prosthesis. Am J Ophthamol. Forthcoming.
  9. Mangione C, Lee P, Gutierrez P, Spritzer K, Berry S, Hays R. Development of the 25-item National Eye Institute Visual Function Questionnaire (VFQ-25). Arch Ophthalmol. 2001;119:1050–1058
  10. Mangione CM, Berry S, Spritzer K, et al. Identifying the content area for 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol. 1998;116:227–233
  11. Steinberg EP, Tielsch JM, Schein OD, et al. The VF-14 (An index of functional impairment in patients with cataract). Arch Ophthalmol. 1994;112:630–638
  12. Boisjoly H, Gresset J, Charest M, et al. The VF-14 index of visual function in recipients of a corneal graft: a 2-year Follow-up study. Am J Ophthalmol. 2002;134:166–171
  13. American Academy of Ophthalmology and American Society of Cataract and Refractive Surgery. White paper on cataract surgery. J Cataract Refractive Surg. 1996;22:645–650
  14. Agency for Health Care Policy and Research. Cataract in adults: management of functional impairment, 1993. http://www.ahrq.gov/clinic/medtep/catguide.htmAccessed: July 7, 2009
  15. Mendes F, Schaumberg D, Navon S, et al. Assessment of visual function after corneal transplantation: the quality of life and psychometric assessment after corneal transplantation (Q-PACT) Study. Am J Ophthalmol. 2003;135:785–793
  16. Friedman DS, Tielsch JM, Vitale S, Bass EB, Schein OD, Steinberg EP. VF-14 Item specific responses in patients undergoing first eye cataract surgery: can the length of the VF-14 be reduced?. Br J Ophthalmol. 2002;86:885–891

PII: S0002-9394(09)00555-8

doi: 10.1016/j.ajo.2009.07.037

American Journal of Ophthalmology
Volume 149, Issue 1 , Pages 54-61.e2 , January 2010

Article Tools

* Image Usage & Resolution